Natera, INC Form 4 insider transactions

Daniel Rabinowitz, SEC. AND CHIEF LEGAL OFFICER of Natera, Inc., reports the vesting of restricted stock units and subsequent sale of shares to cover tax obligations.

Natera's CEO, Steven Chapman, reports the acquisition and disposal of common stock and restricted stock units.

Michael Brophy, CFO of Natera, Inc., reports the vesting of restricted stock units and subsequent sale of shares to cover tax obligations.

Director Brinkley Ruth Williams acquired 2,964 restricted stock units (RSUs) of Natera, Inc. on June 28, 2024, which vest on June 12, 2025, or upon a change in control.

Director Rosenman Herm acquired 2,964 restricted stock units (RSUs) of Natera, Inc. on June 28, 2024, which vest on June 12, 2025.

Director Marcus Gail Boxer reported the acquisition of 2,964 restricted stock units (RSUs) of Natera, Inc. on June 28, 2024, according to a Form 4 filing.

Director James Healy reports the acquisition of 2,964 restricted stock units (RSUs) of Natera, Inc. on June 28, 2024, vesting fully on June 12, 2025, with accelerated vesting upon a change in control.

Director Rowan E. Chapman reports acquisition of 2,964 restricted stock units (RSUs) of Natera, Inc. on June 28, 2024.

Director Roelof Botha reports acquisition of restricted stock units and transfer of shares to an estate planning vehicle.

Roy D. Baynes, a director at Natera, Inc., reported the acquisition of 2,964 restricted stock units (RSUs) on June 28, 2024.

Jonathan Sheena, co-founder of Natera, Inc., sold 2,700 shares of common stock at an average price of $109.6591 under a pre-arranged Rule 10b5-1 trading plan.

Natera's CEO, Steven Chapman, sold a portion of his common stock holdings under a pre-arranged Rule 10b5-1 trading plan.

Gail Boxer Marcus, a director at Natera, Inc., sold 2,000 shares of common stock at a price of $110.165 per share on May 30, 2024.

Solomon Moshkevich, President of Clinical Diagnostics at Natera, Inc., sold 1,647 shares of common stock on May 28, 2024, to cover tax obligations related to vesting RSUs.

John Fesko, President and Chief Business Officer of Natera, Inc., sold 1,438 shares of common stock on May 28, 2024, to cover tax obligations related to vesting RSUs.

Director Rowan E. Chapman of Natera, Inc. sold 4,856 shares of common stock at an average price of $109.0874 on May 28, 2024.

Jonathan Sheena, co-founder of Natera, Inc., sold shares of common stock on May 23, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Jonathan Sheena, co-founder of Natera, Inc., reports a donation of 11,853 common stock shares to a charitable foundation on May 16, 2024.

Natera's CEO, Steven Chapman, executed sales of common stock on May 15, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Daniel Rabinowitz, SEC. AND CHIEF LEGAL OFFICER of Natera, Inc., exercised stock options and sold shares of common stock on May 10, 2024, according to a recent SEC Form 4 filing.

Jonathan Sheena, co-founder of Natera, Inc., sold a portion of their common stock holdings on May 10, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Matthew Rabinowitz, Executive Chairman of Natera, Inc., exercised stock options and sold 215,000 shares of common stock on May 8, 2024.

Natera's CFO, Michael Burkes Brophy, executed multiple sales of common stock on May 1, 2024, under a pre-arranged Rule 10b5-1 trading plan.

John Fesko, President and Chief Business Officer of Natera, Inc., sold 929 shares of common stock on April 29, 2024, to cover tax obligations related to vesting RSUs.

Solomon Moshkevich, President of Clinical Diagnostics at Natera, Inc., sold 1,196 shares of common stock on April 29, 2024, to satisfy tax withholding obligations related to vesting RSUs.

Daniel Rabinowitz, SEC. AND CHIEF LEGAL OFFICER of Natera, Inc., sold 1,057 shares of common stock on April 29, 2024, to cover tax obligations related to vesting RSUs.

Natera's CEO, Steven Chapman, sold 4,084 shares of common stock on April 29, 2024, at a price of $93.1387 per share to cover tax obligations related to vesting RSUs.

Michael Brophy, CFO of Natera, Inc., sold 1,238 shares of common stock on April 29, 2024, to satisfy tax withholding obligations related to vesting RSUs.

Director James Healy received 210 Restricted Stock Units (RSUs) from Natera, Inc. in lieu of quarterly retainer fees.

Director Roy D. Baynes acquired 169 shares of Natera, Inc. common stock through the issuance of fully vested Restricted Stock Units (RSUs) in lieu of quarterly retainer fees.